Federal Decree-Law No. (38) of 2024

We, Mohammed Bin Zayed Al Nahyan, President of the United Arab Emirates;

• Upon reviewing the Constitution;
• Federal Law No. (1) of 1972 Concerning the Competences of Ministries and the Powers of Ministers, as amended;
• Federal Law No. (4) of 2015 Concerning Private Health Establishments, and as amended;
• Federal Decree-Law No. (4) of 2016 Concerning Medical Liability, as amended;
• Federal Law No. (9) of 2017 Concerning Veterinary Preparations;
• Federal Law No. (8) of 2019 Concerning Medical Products, Pharmacists and Pharmaceutical Establishments, as amended;
• Federal Law No. (11) of 2021 Regulating and Protecting the Industrial Property Rights;
• Federal Law No. (30) of 2021 Combating Narcotics and Psychotropic Substances, as amended;
• Federal Decree-Law No. (32) of 2021 Concerning Commercial Companies;
• Federal Law No. (3) of 2022 Regulating the Commercial Agencies;
• Federal Decree-Law No. (28) of 2023 Establishing the Emirates Drug Establishment (EDE);
• Federal Decree-Law No. (49) of 2023 Regulating the Use of the Human Genome,

Based on the proposal of His Highness, Chairman of the UAE Space EDE, and the approval of the Cabinet,

Have promulgated the following Decree-Law: